Skip to Main content Skip to Navigation
Journal articles

Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications

Abstract : A high expression of the phosphoprotein osteopontin (OPN) has been associated with cancer progression in several tumor types, including breast cancer, hepatocarcinoma, ovarian cancer, and colorectal cancer (CRC). Interestingly, OPN is overexpressed in CRC and is associated with a poor prognosis linked to invasion and metastasis. Here, we review the regulation and functions of OPN with an emphasis on CRC. We examine how epigenetic and genetic regulators interact with the key signaling pathways involved in this disease. Then, we describe the role of OPN in cancer progression, including proliferation, survival, migration, invasion, and angiogenesis. Furthermore, we outline the interest of using OPN as a clinical biomarker, and discuss if and how osteopontin can be implemented as a routine assay in clinical laboratories for monitoring CRC patients. Finally, we discuss the use of OPN an attractive, but challenging, therapeutic target.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03447091
Contributor : Michèle Sabbah Connect in order to contact the contributor
Submitted on : Wednesday, November 24, 2021 - 4:18:58 PM
Last modification on : Friday, November 26, 2021 - 3:46:02 AM

File

cancers-13-03793.pdf
Publisher files allowed on an open archive

Identifiers

Citation

Katyana Amilca-Seba, Michèle Sabbah, Annette Larsen, Jérôme Denis. Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications. Cancers, MDPI, 2021, 13 (15), pp.3793. ⟨10.3390/cancers13153793⟩. ⟨inserm-03447091⟩

Share

Metrics

Record views

12

Files downloads

15